Table 2.
Transfer of primed T cells: Kinetics of CTLp and of protection depended on time after transfer, route of infection, and irradiation of recipient
Treatment of recipient* | Time after transfer† | CTLp | Virus titer (log10 )
|
Survival LCMV i.c.¶ | |
---|---|---|---|---|---|
LCMV i.v.‡ | vacc-GP i.p.§ | ||||
– | Control | <1:106 | 5.8 ± 0.1 | 5.9 ± 0.2 | 0/3 |
– | d + 1 | 1:4 × 104 | <2.3 | 1.1 ± 1.0 | 0/3 |
– | d + 45 | 1:3 × 104 | <2.3 | 5.8 ± 0.3 | 0/3 |
Irradiated | d + 45 | 1:3 × 104 | <2.3 | <1 | 3/3 |
Mice were irradiated with 4.5 Gy.
Spleen cells (3 × 107) from LCMV-immune mice (day 100) were injected i.v.; control mice received spleen cells from unimmunized mice.
Mice were challenged i.v. with 200 pfu LCMV WE.
Mice were challenged i.p. with 5 × 106 pfu vacc-GP.
Mice were challenged i.c. with 30 pfu LCMV WE.